Nephros Inc. (NEPH) Share Price Today, Stock Analysis, Annual Report | Value Research Nephros Inc. (NEPH) - Get live share price today, stock analysis, price valuation, performance, fundamentals, market cap, share holding, financial report of US stocks.
  • Price Change
  • Market Capitalisation market-capitalisation-info $19 Mln

  • 12 Month Earnings monthly-earning $-4 Mln
  • Price to Earnings price-to-earning --

Nephros Inc. (NEPH) Share Price

$1.41

As on 22-Sep-2023 16:00 EDT

up-down-arrow $-0.01-0.70%

  • Prev Close info

    $1.42

  • Day's Openinfo

    $1.41

  • Today's Highinfo

    $1.43

  • Today's Lowinfo

    $1.41

  • Today's Volumeinfo

    5,243

Please wait...

Nephros Inc. (NEPH) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Nephros (NEPH)
21.55 -14.03 -18.50 38.24 -39.38 -23.03 -18.42
S&P BSE Sensex*
8.52 1.18 4.83 13.64 21.78 12.71 12.73
#
-- -- -- -- -- -- --
As on 22-Sep-2023  |  *As on 25-Sep-2023  |  #As on
2022
2021
2020
2019
2018
2017
2016
Nephros (NEPH)
-80.34 -31.24 -13.77 93.96 26.48 22.94 69.93
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Nephros Inc. (NEPH) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Nephros Inc. (NEPH)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        CEO, CFO, Pres & Director

        Mr. Andrew Astor

        VP of Marketing & Bus. Devel.

        Ms. Joleen C. Turner

        Headquarters

        South Orange, NJ

        FAQs for Nephros Inc. (NEPH)

        The total asset value of Nephros Inc. (NEPH) stood at $ 12 Mln as on 31-Mar-23

        The share price of Nephros Inc. (NEPH) is $1.410000 (NASDAQ) as of 22-Sep-2023 16:00 EDT. Nephros Inc. (NEPH) has given a return of -39.38% in the last 3 years.

        Nephros Inc. (NEPH) has a market capitalisation of $ 19 Mln as on 02-Jun-2023. As per Value Research classification, it is a company.

        The P/B ratio of Nephros Inc. (NEPH) is 1.65 times as on 02-Jun-2023, a -0.59% premium to its peers’ median range of 4.02 times.

        Since, TTM earnings of Nephros Inc. (NEPH) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Nephros Inc. (NEPH) and enter the required number of quantities and click on buy to purchase the shares of Nephros Inc. (NEPH).

        Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

        The CEO & director of Mr. Andrew Astor. is Nephros Inc. (NEPH), and CFO & Sr. VP is Ms. Joleen C. Turner.

        The promoters of Nephros Inc. (NEPH) have pledged 0% of the total equity as on Mar-23.

        Nephros Inc. (NEPH) Ratios
        Return on equity(%)
        -73.53
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0
        Dividend yield(%)
        0

        No, TTM profit after tax of Nephros Inc. (NEPH) was $-4 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $18.77 Mln
        • Revenue (TTM)revenue-information $11.55 Mln
        • Earnings (TTM) earning-information $-4.43 Mln
        • Cash date-information $3.84 Mln
        • Total Debt info $0.93 Mln
        • Insider's Holding 11.53%
        • Liquidity liquidity Moderate
        • 52 Week range week-range $0.91 - 2.50
        • Shares outstanding share-outstanding 10,484,900
        • 10 Years Aggregate:

          CFO: $-29.57 Mln

          EBITDA: $-36.50 Mln

          Net Profit: $-40.08 Mln

        About The Company

        • IPO Date 21-Sep-2004
        • CEO, CFO, Pres & Director Mr. Andrew Astor
        • VP of Marketing & Bus. Devel. Ms. Joleen C. Turner
        • Listing key-listing NASDAQ: NEPH
        • Country United States
        • Headquarters headquarters South Orange, NJ
        • Website website https://www.nephros.com
        • Business

          Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration...  products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        share-fund-plan-icon